Support PenkeMerck & Company Inc - Trending symbols
Latest News of Merck & Company Inc
| Date | Title | Read |
|---|---|---|
| 2025-09-11 19:42 | Merck (MRK) Announces Positive Phase 3 Results For 21-Valent Pneumococcal Vaccine | Read |
| 2025-09-10 20:33 | US drugmaker scraps plans for £1bn UK research centre | Read |
| 2025-09-10 06:59 | Guggenheim Initiates Summit Therapeutics (SMMT) With a Buy Rating | Read |
| 2025-09-05 20:17 | Companies tap US bond market for nearly $70 billion, starting September on a busy note | Read |
| 2025-09-05 11:50 | Lyophilized Injectable Drugs Market Report 2025-2033 | R&D Efforts to Improve Safety and Reconstitution Time, Alongside Expanding CDMO Services and Emerging Market Contributions | Read |
| 2025-08-19 19:29 | Merck (MRK) Antibody Drug Ifinatamab Deruxtecan Gains Breakthrough Therapy Designation | Read |
| 2025-08-19 17:37 | MRK's ADC Candidate Gets FDA Breakthrough Therapy Tag for Lung Cancer | Read |
| 2025-08-17 08:30 | Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial | Read |
| 2025-08-14 01:05 | China pharma firms turn to local reagent suppliers to cut costs and delivery times | Read |
Trends
| 2024-06-30 | 2024-09-30 | 2024-12-31 | 2025-03-31 | 2025-06-30 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Other Income Expense Net | 2,195,431 | 3,505,310 | 5,700,741 | -5,626,945 | 73,796 | 3,062,534 | 3,136,330 | -8,984,663 | -5,848,333 | |
| Tax Provision | 8,248,680 | 5,499,120 | 13,747,800 | -3,132,832 | 10,614,968 | 3,882,712 | 14,497,680 | -28,162,160 | -13,664,480 | |
| Income before Tax | 78,006,495 | -15,716,040 | 62,290,455 | -1,216,950 | 61,073,505 | 2,381,745 | 63,455,250 | -156,204,225 | -92,748,975 | |
| Net Income | 68,566,440 | -12,099,960 | 56,466,480 | -4,015,935 | 52,450,545 | -3,407,460 | 49,043,085 | -152,918,460 | -103,875,375 | |
| EBITDA | 88,089,795 | -16,706,985 | 71,382,810 | -10,761,315 | 60,621,495 | 5,545,815 | 66,167,310 | -153,300,930 | -87,133,620 | |
| Operating Income | 88,089,795 | -16,706,985 | 71,382,810 | -10,761,315 | 60,621,495 | 5,545,815 | 66,167,310 | -153,300,930 | -87,133,620 | |
| Net Income from Continuing Operations | 68,653,365 | -12,099,960 | 56,553,405 | -4,085,475 | 52,467,930 | -3,355,305 | 49,112,625 | -152,935,845 | -103,823,220 |
Comments
How you think about this?